| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M506431200 |
| P698 | PubMed publication ID | 16547010 |
| P2093 | author name string | Masashi Miyano | |
| Tsuyoshi Inoue | |||
| Kosuke Aritake | |||
| Yoshihiro Urade | |||
| Yuji Kado | |||
| P2860 | cites work | Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep | Q22253983 |
| Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 | Q24290855 | ||
| Mechanism of metal activation of human hematopoietic prostaglandin D synthase | Q24297334 | ||
| 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes | Q24320095 | ||
| Prostaglandin D synthase in human megakaryoblastic cells | Q24322892 | ||
| Improved methods for building protein models in electron density maps and the location of errors in these models | Q26776980 | ||
| Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 | ||
| MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures | Q26778412 | ||
| Cloning and crystal structure of hematopoietic prostaglandin D synthase | Q27745550 | ||
| Raster3D Version 2.0. A program for photorealistic molecular graphics | Q27860485 | ||
| Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse | Q28238317 | ||
| Hydrogen bonds with pi-acceptors in proteins: frequencies and role in stabilizing local 3D structures | Q31816290 | ||
| Prostaglandin D synthase: structure and function | Q33834101 | ||
| Hematopoietic prostaglandin D synthase | Q34219405 | ||
| First determination of the inhibitor complex structure of human hematopoietic prostaglandin D synthase. | Q34316991 | ||
| Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives | Q34340684 | ||
| Induction of hematopoietic prostaglandin D synthase in human megakaryocytic cells by phorbol ester | Q34451773 | ||
| Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice | Q34852356 | ||
| Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors | Q36692674 | ||
| Structural basis of hematopoietic prostaglandin D synthase activity elucidated by site-directed mutagenesis | Q38311013 | ||
| Protein kinase C activates human lipocalin-type prostaglandin D synthase gene expression through de-repression of notch-HES signaling and enhancement of AP-2 beta function in brain-derived TE671 cells. | Q40451710 | ||
| RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines | Q40682143 | ||
| Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. | Q40797404 | ||
| Induction of cyclooxygenase-1 in a human megakaryoblastic cell line (CMK) differentiated by phorbol ester | Q41134952 | ||
| Characterization of the unfolding process of lipocalin-type prostaglandin D synthase | Q44222490 | ||
| Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism | Q44259074 | ||
| Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats | Q44585538 | ||
| COX-2 inhibitors--lessons in drug safety | Q45267551 | ||
| Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages | Q46236501 | ||
| Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. | Q46418233 | ||
| Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic effects in various experimental models | Q46690846 | ||
| Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects | Q46834818 | ||
| Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa | Q47425685 | ||
| Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. | Q48577686 | ||
| Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase | Q56592820 | ||
| Identification and isolation of a membrane protein necessary for leukotriene production | Q59059824 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 15277-15286 | |
| P577 | publication date | 2006-03-17 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase | |
| P478 | volume | 281 |
| Q42829127 | A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c |
| Q42576987 | An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production |
| Q42581400 | Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase |
| Q33528245 | Comparison of PGH2 binding site in prostaglandin synthases. |
| Q38485579 | Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) |
| Q24630614 | Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis |
| Q39201570 | Eosinophils in human oral squamous carcinoma; role of prostaglandin D2. |
| Q44548551 | Expression and detrimental role of hematopoietic prostaglandin D synthase in spinal cord contusion injury |
| Q35872751 | Hematopoetic prostaglandin D synthase: an ESR1-dependent oviductal epithelial cell synthase |
| Q84879543 | Hematopoietic prostaglandin D synthase (H-Pgds) is expressed in the early embryonic gonad and participates to the initial nuclear translocation of the SOX9 protein |
| Q34633614 | Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology. |
| Q33967499 | High-quality crystals of human haematopoietic prostaglandin D synthase with novel inhibitors |
| Q34416262 | Improvement in the quality of hematopoietic prostaglandin D synthase crystals in a microgravity environment |
| Q37164193 | Inhibition of prostaglandin D synthase suppresses muscular necrosis |
| Q57284969 | L-Pgds but not H-Pgds deletion causes hypertension and accelerates thrombogenesis in mice |
| Q40601963 | Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease |
| Q41041451 | Mast cells contribute to double-stranded RNA-induced augmentation of airway eosinophilia in a murine model of asthma |
| Q47777584 | Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1. |
| Q45961332 | Obesity-induced changes in lipid mediators persist after weight loss. |
| Q36076180 | PGD synthase and PGD2 in immune resposne |
| Q36662906 | PGD(2) DP1 receptor protects brain from ischemia-reperfusion injury. |
| Q28731227 | PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2 |
| Q39449759 | Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase |
| Q43171502 | Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo. |
| Q48577686 | Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. |
| Q48156771 | Prostaglandins D2 and E2 have opposite effects on alveolar macrophages infected with Histoplasma capsulatum. |
| Q41050351 | Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets. |
| Q35173433 | Selenium levels affect the IL-4-induced expression of alternative activation markers in murine macrophages |
| Q37855791 | Sigma-class glutathione transferases. |
| Q27643949 | Structural Basis of the Catalytic Mechanism Operating in Open-Closed Conformers of Lipocalin Type Prostaglandin D Synthase |
| Q41955640 | Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice |
| Q30486745 | The Concise Guide to PHARMACOLOGY 2013/14: enzymes. |
| Q60687194 | The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages |
| Q92941365 | Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation |
| Q30864246 | Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide |
| Q34368348 | Virtual fragment screening: exploration of MM-PBSA re-scoring |
Search more.